Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RIBAVIRIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 849 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Andreone, P; Gramenzi, A; Cursaro, C; Biselli, M; Di Giammarino, L; Grazi, GL; Jovine, E; D'Errico, A; Galli, S; Mazziotti, A; Cavallari, A; Bernardi, M
      Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study

      DIGESTIVE AND LIVER DISEASE
    2. Capra, F; De Maria, E; Franchini, M; Gandini, G
      Effective antiviral treatment for hepatitis C virus-related chronic activehepatitis in haemophiliac patients

      DIGESTIVE AND LIVER DISEASE
    3. Puoti, M; Cadeo, GP; Putzolu, V; Forleo, MA; Barni, MC; Cristini, G; Rossi, S; Spinetti, A; Zaltron, S; Zanini, B; Quiros-Roldan, E; Paraninfo, G; Gargiulo, F; Carosi, G
      Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone

      DIGESTIVE AND LIVER DISEASE
    4. Berenguer, M; Rayon, JM; Prieto, M; Aguilera, V; Nicolas, D; Ortiz, V; Carrasco, D; Lopez-Andujar, R; Mir, J; Berenguer, J
      Are posttransplantation protocol liver biopsies useful in the long term?

      LIVER TRANSPLANTATION
    5. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Chapel, HM; Christie, JML; Peach, V; Chapman, RWG
      Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C

      CLINICAL IMMUNOLOGY
    7. Jowett, SL; Agarwal, K; Smith, BC; Craig, W; Hewett, M; Bassendine, DR; Gilvarry, E; Burt, AD; Basendine, MF
      Managing chronic hepatitis C acquired through intravenous drug use

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    8. Sasadeusz, J
      Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones

      INTERNAL MEDICINE JOURNAL
    9. Moradpour, D; Cerny, A; Heim, MH; Blum, HE
      Hepatitis C: an update

      SWISS MEDICAL WEEKLY
    10. Arens, M
      Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV

      JOURNAL OF CLINICAL VIROLOGY
    11. Schinkel, J; Kroes, ACM; Wagtmans, MJ; Lamers, CBHW; van Hoek, B
      Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays

      JOURNAL OF CLINICAL VIROLOGY
    12. Erensoy, S
      Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy

      JOURNAL OF CLINICAL VIROLOGY
    13. Levis, J; Kenny-Walsh, E; O'Sullivan, K; Horgan, M; Whelton, M; Shanahan, F; Fanning, L
      Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification

      JOURNAL OF CLINICAL VIROLOGY
    14. Jorgensen, PA; Neuwald, PD
      Standardized hepatitis C virus RNA panels for nucleic acid testing assays

      JOURNAL OF CLINICAL VIROLOGY
    15. Grahovac, B; Bingulac-Popovic, J; Vucelic, B; Hrstic, I; Ostojic, R; Drazic, V; Balija, M; Grgicevic, D
      Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C

      JOURNAL OF CLINICAL VIROLOGY
    16. Arase, Y; Chayama, K; Ikeda, K; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Suzuki, F; Akuta, N; Someya, T; Kobayashi, M; Kumada, H
      Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C

      HEPATOLOGY RESEARCH
    17. Okanoue, T; Daimon, Y; Kirishima, T; Ohnishi, N; Nakamura, H; Nagao, Y; Minami, M; Itoh, Y
      Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients

      HEPATOLOGY RESEARCH
    18. Bacosi, M; Patsouri, M; Miglioresi, L; Patrizi, F; Russo, F; Ricci, GL
      Combined treatment of HCV infection: is there a need for meta-analysis?

      HEPATOLOGY RESEARCH
    19. Hwang, SJ; Lee, SD; Chu, CW; Lu, RH; Chang, FY
      An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C

      HEPATOLOGY RESEARCH
    20. Zein, NN
      Experimental and emerging therapies for chronic hepatitis C virus infection

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    21. Prince, GA
      An update on respiratory syncytial virus antiviral agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    22. Pankiewicz, KW
      Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    23. Macejak, DG; Jensen, KL; Pavco, PA; Phipps, KM; Heinz, BA; Colacino, JM; Blatt, LM
      Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA

      JOURNAL OF VIRAL HEPATITIS
    24. McHutchison, JG; Shad, JA; Gordon, SC; Morgan, TR; Ling, MH; Garaud, JJ; Albrecht, JK; Dienstag, JL
      Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy

      JOURNAL OF VIRAL HEPATITIS
    25. Takagi, H; Nagamine, T; Abe, T; Takayama, H; Sato, K; Otsuka, T; Kakizaki, S; Hashimoto, Y; Matsumoto, T; Kojima, A; Takezawa, J; Suzuki, K; Sato, S; Mori, M
      Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    26. Shehab, TM; Sonnad, SS; Lok, ASF
      Management of hepatitis C patients by primary care physicians in the USA: results of a national survey

      JOURNAL OF VIRAL HEPATITIS
    27. Kinzie, JL; Naylor, PH; Nathani, MG; Peleman, RR; Ehrinpreis, MN; Lybik, M; Turner, JR; Janisse, JJ; Massanari, M; Mutchnick, MG
      African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians

      JOURNAL OF VIRAL HEPATITIS
    28. Teuber, G; Berg, T; Naumann, U; Raedle, J; Brinkmann, S; Hopf, U; Zeuzem, S
      Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    29. Bruchfeld, A; Stahle, L; Andersson, J; Schvarcz, R
      Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study

      JOURNAL OF VIRAL HEPATITIS
    30. Teixeira, R; Papatheodoridis, GV; Burroughs, AK
      Management of recurrent hepatitis C after liver transplantation

      JOURNAL OF VIRAL HEPATITIS
    31. Katayama, K; Kasahara, A; Sasaki, Y; Kashiwagi, T; Naito, M; Masuzawa, M; Katoh, M; Yoshihara, H; Kamada, T; Mukuda, T; Hijioka, T; Hori, M; Hayashi, N
      Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance

      JOURNAL OF VIRAL HEPATITIS
    32. Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M
      In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    33. Querenghi, F; Yu, Q; Billaud, G; Maertens, G; Trepo, C; Zoulim, F
      Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

      JOURNAL OF VIRAL HEPATITIS
    34. Aguilar, C; Lucia, JF; Simon, MA
      An emerging role for interferon in haemophiliacs with chronic hepatitis C?

      HAEMOPHILIA
    35. Kozlowski, A; Charles, SA; Harris, JM
      Development of pegylated interferons for the treatment of chronic hepatitis C

      BIODRUGS
    36. Collier, J; Chapman, R
      Combination therapy with interferon-alpha and ribavirin for hepatitis C - Practical treatment issues

      BIODRUGS
    37. Koff, RS
      Disease management programs for hepatitis C - A team approach to setting goals

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    38. Batra, N
      Hepatitis C screening and treatment versus liver transplantation - A financial option appraisal and commissioning model for purchasers

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    39. Saenz, MJ
      Treatment of chronic hepatitis C in refractory patients. What is the answer?

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    40. Diago, M; Lujan, M; Valeros, D; Tuset, C; Marcaida, G; Garcia, V; Cors, R; Carbonell, P
      Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    41. Edelstein, MA; Martin, P
      Chronic hepatitis C: Current status and rationale for antiviral therapy

      EUROPEAN JOURNAL OF SURGERY
    42. Aurisicchio, L; Ceccacci, A; La Monica, N; Palombo, F; Traboni, C
      Tamarin alpha-interferon is active in mouse liver upon intramuscular gene delivery

      JOURNAL OF GENE MEDICINE
    43. Hoffman, JA; Shah, AJ; Ross, LA; Kapoor, N
      Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    44. Strickland, DK; Jenkins, JJ; Hudson, MM
      Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    45. Simoes, EAF
      Treatment and prevention of respiratory syncytial virus lower respiratory tract infection

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    46. Vilchez, RA; McCurry, K; Dauber, J; Iacono, A; Keenan, R; Zeevi, A; Griffith, B; Kusne, S
      The epidemiology of parainfluenza virus infection in lung transplant recipients

      CLINICAL INFECTIOUS DISEASES
    47. Isaacson, M
      Viral hemorrhagic fever hazards for travelers in Africa

      CLINICAL INFECTIOUS DISEASES
    48. Rosenberg, PM
      Hepatitis C: A hepatologist's approach to an infectious disease

      CLINICAL INFECTIOUS DISEASES
    49. La Rosa, AM; Champlin, RE; Mirza, N; Gajewski, J; Giralt, S; Rolston, KV; Raad, I; Jacobson, K; Kontoyiannis, D; Elting, L; Whimbey, E
      Adenovirus infections in adult recipients of blood and marrow transplants

      CLINICAL INFECTIOUS DISEASES
    50. Hogan, WJ; Edwards, WD; Macon, WR; Habermann, TM
      Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    51. Fang, SH; Lai, MY; Hwang, LH; Yang, PM; Chen, PJ; Chiang, BL; Chen, DS
      Ribavirin enhances interferon-gamma levels in patients with chronic hepatitis C treated with interferon-alpha

      JOURNAL OF BIOMEDICAL SCIENCE
    52. Davis, GL
      Treatment of chronic hepatitis C - Combination therapy permanently eradicates the virus in at least 40% of patients

      BRITISH MEDICAL JOURNAL
    53. Gow, PJ; Mutimer, D
      Regular review - Treatment of chronic hepatitis

      BRITISH MEDICAL JOURNAL
    54. Ferenci, P; Stauber, R; Steindl-Munda, P; Gschwantler, M; Fickert, P; Datz, C; Muller, C; Hackl, F; Rainer, W; Watkins-Riedel, T; Lin, W; Krejs, GJ; Gangl, A
      Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    55. Zeuzem, S
      What is (cost) effective in patients with chronic hepatitis C virus infection?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    56. Sagmeister, M; Wong, JB; Mullhaupt, B; Renner, EL
      A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    57. Everard, ML; Swarbrick, A; Rigby, AS; Milner, AD
      The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity

      RESPIRATORY MEDICINE
    58. Nguyen, MH; Wright, TL
      Therapeutic advances in the management of hepatitis B and hepatitis C

      CURRENT OPINION IN INFECTIOUS DISEASES
    59. Kimpen, JLL
      Management of respiratory syncytial virus infection

      CURRENT OPINION IN INFECTIOUS DISEASES
    60. Desch, S; Vaeth, T; Tamba, M; Klinker, H; Langmann, P
      Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2A in treatment-naive patients with chronic hepatitis C and HCV genotype 1

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    61. Tossing, G
      Therapy of chronic hepatitis B and C and treatment options in HCV-HIV co-infection - European Conference on Infectious Diseases and Tropical Medicine- EuCID 2001, 3-6 May 2001, Leipzig

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    62. Malaguarnera, M; Restuccia, S; Ferlito, L; Mazzoleni, G; Giugno, I; Pistone, G
      Antiviral drugs in chronic hepatitis B: review and meta-analysis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    63. Suzuki, F; Chayama, K; Tsubota, A; Akuta, N; Someya, T; Kobayashi, M; Suzuki, Y; Saitoh, S; Arase, Y; Ikeda, K; Kumada, H
      Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen

      JOURNAL OF GASTROENTEROLOGY
    64. Izumi, N
      How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C

      JOURNAL OF GASTROENTEROLOGY
    65. Nakamura, H
      Efficacy of amantadine hydrochloride in patients with chronic hepatitis C

      JOURNAL OF GASTROENTEROLOGY
    66. Dussol, B; Moal, V; Daniel, L; Pain, C; Berland, Y
      Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    67. Labbe, A
      Antibiotics and antiviral drugs

      ARCHIVES DE PEDIATRIE
    68. Thumerelle, C
      Therapeutic aspects of infantile bronchiolitis (excluding corticosteroids and bronchodilators)

      ARCHIVES DE PEDIATRIE
    69. Par, A; Telegdy, L; Dalmi, L; Muller, E
      Therapy for chronic hepatitis C

      JOURNAL OF PHYSIOLOGY-PARIS
    70. De Clercq, E
      Hamao Umezawa Memorial Award lecture 'an odyssey in the viral chemotherapyfield'

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    71. Murphy, ME; Kariwa, H; Mizutani, T; Tanabe, H; Yoshimatsu, K; Arikawa, J; Takashima, I
      Characterization of in vitro and in vivo antiviral activity of lactoferrinand ribavirin upon hantavirus

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    72. Payne, DA; Seifert, SL; Brody, BA
      Effects of storage and viral load on hepatitis C viral genotyping

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    73. Nakamuta, M; Fukutomi, T; Shimohashi, N; Kinukawa, N; Uchimura, K; Tada, S; Motomura, K; Enjoji, M; Kato, M; Iwamoto, H; Tanabe, Y; Imari, Y; Sakamoto, S; Sakai, H; Nawata, H
      Kinetics of the hepatitis C virus during interferon therapy as a marker oftherapeutic response

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    74. Greenough, A
      Recent advances in the management and prophylaxis of respiratory syncytialvirus infection

      ACTA PAEDIATRICA
    75. Gordon, SC
      Treatment of viral hepatitis - 2001

      ANNALS OF MEDICINE
    76. Loubiere, S; Rotily, M; Durand-Zaleski, I; Costagliola, D; Moatti, JP
      Adjunction of polymerase chain reaction in screening for hepatitis C virusRNA in blood donations: misuse of the principle of caution

      M S-MEDECINE SCIENCES
    77. Trepo, C; Merle, P
      Can the new pegylated interferon cure hepatitis C?

      PRESSE MEDICALE
    78. Sobesky, R; Buffet, C
      Management of patients with hepatitic C viral infection

      PRESSE MEDICALE
    79. Niederau, C
      Diagnosis and treatment of chronic hepatitis C: Practical recommendations and new developments

      MEDIZINISCHE KLINIK
    80. Castera, L; Roulot, D; Trinchet, JC; Beaugrand, M
      Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    81. Pol, S; Fontaine, H; Vallet-Pichard, A
      Synopsis: Treatments for hepatitis virus C infections

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    82. Snell, NJC
      New treatments for viral respiratory tract infections - opportunities and problems

      Journal of antimicrobial chemotherapy
    83. Torre, F; Campo, N; Giusto, R; Ansaldi, F; Icardi, GC; Picciotto, A
      Antiviral activity of amantadine in elderly patients with chronic hepatitis C

      GERONTOLOGY
    84. Espinosa, M; Rodriguez, M; Martin-Malo, A; de Lara, MAA; Gonzalez, R; Lopez-Rubio, F; de la Mata, M; Aljama, P
      Interferon therapy in hemodialysis patients with chronic hepatitis C virusinfection induces a high rate of long-term sustained virological and biochemical response

      CLINICAL NEPHROLOGY
    85. Sax, H; Friedl, A; Renner, E; Steuerwald, MH; Weber, R
      Pilot study of interferon-alpha with and without amantadine for the treatment of hepatitis C in HIV co-infected individuals on antiretroviral therapy

      INFECTION
    86. Chinchai, T; Noppornpanth, S; Theamboonlers, A; Chongsrisawat, V; Poovorawan, Y
      Acute posttransfusion hepatitis C: Identification of a common hepatitis C virus strain in donor and recipient using polymorphism analysis

      INFECTION
    87. Garini, G; Allegri, L; Carnevali, L; Catellani, W; Manganelli, P; Buzio, C
      Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    88. Lindsay, KL; Trepo, C; Heintges, T; Shiffman, ML; Gordon, SC; Hoefs, JC; Schiff, ER; Goodman, ZD; Laughlin, M; Yao, RJ; Albrecht, JK
      A randomized, double-blind trial comparing pegylated interferon alfa-2b tointerferon alfa-2b as initial treatment for chronic hepatitis C

      HEPATOLOGY
    89. Spinzi, G; Minoli, G
      To biopsy or not to biopsy

      HEPATOLOGY
    90. Podevin, P; Sabile, A; Gajardo, R; Delhem, N; Abadie, A; Lozach, PY; Beretta, L; Brechot, C
      Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cellline inhibits the antiviral effect of interferon in a PKR-independent manner

      HEPATOLOGY
    91. Kronenberger, B; Ruster, B; Elez, R; Weber, S; Piiper, A; Lee, JH; Roth, WK; Zeuzem, S
      Interferon alfa down-regulates CD81 in patients with chronic hepatitis C

      HEPATOLOGY
    92. Mangia, A; Minerva, N; Annese, M; Leandro, G; Villani, MR; Santoro, R; Carretta, V; Bacca, D; Giangaspero, A; Bisceglia, M; Ventrella, F; Dell'Erba, G; Andriulli, A
      A randomized trial of amantadine and interferon versus interferon alone asinitial treatment for chronic hepatitis C

      HEPATOLOGY
    93. Di Bisceglie, AM; Thompson, J; Smith-Wilkaitis, N; Brunt, EM; Bacon, BR
      Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon

      HEPATOLOGY
    94. Reddy, KR; Wright, TL; Pockros, PJ; Shiffman, M; Everson, G; Reindollar, R; Fried, MW; Purdum, PP; Jensen, D; Smith, C; Lee, WM; Boyer, TD; Lin, A; Pedder, S; DePamphilis, J
      Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared withinterferon alpha-2a in noncirrhotic patients with chronic hepatitis C

      HEPATOLOGY
    95. Cheng, SJ; Bonis, PAL; Lau, J; Pham, NQ; Wong, JB
      Interferon and ribavirin for patients with chronic hepatitis C who did notrespond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials

      HEPATOLOGY
    96. Landau, A; Batisse, D; Piketty, C; Van Huyen, LPD; Bloch, F; Belec, L; Bruneval, P; Weiss, L; Jian, R; Kazatchkine, MD
      Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

      AIDS
    97. Nasti, G; Di Gennaro, G; Tavio, M; Cadorin, L; Tedeschi, RM; Talamini, R; Carbone, A; Tirelli, U
      Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

      AIDS
    98. Di Marco, V; Vaccaro, A; Ferraro, D; Alaimo, G; Rodolico, V; Parisi, P; Peralta, S; Di Stefano, R; Almasio, PL; Craxi, A
      High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    99. Papatheodoridis, GV; Papadimitropoulos, VC; Hadziyannis, SJ
      Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    100. Hadziyannis, AS; Papaioannou, C; Spanou, F; Manesis, EK; Hadziyannis, SJ
      Induction interferon therapy in nave patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 03:37:59